PETS
PetMed Express Inc
1.40$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.0% | +6.5% | +1.0% | -12.8% | -4.4% | -0.8% | -24.1% | -8.7% | -12.3% | -7.7% | -21.5% | |
| – | -20.0% | +12.9% | -2.0% | -17.1% | -8.8% | -3.4% | -0.7% | -12.4% | -18.4% | -10.2% | -36.6% | |
| – | -13.1% | -7.5% | +11.8% | -16.8% | +13.2% | -3.7% | -17.9% | -12.2% | -25.4% | -20.4% | -38.9% | |
| – | -13.1% | – | – | -16.8% | +13.2% | -3.7% | – | – | -25.4% | -20.4% | -38.9% | |
| – | +14.8% | -11.2% | +70.1% | -31.1% | -28.4% | +39.4% | -29.0% | +22.4% | -20.7% | +22.4% | -10.6% | |
| – | -41.5% | +82.9% | -17.4% | -10.6% | -48.7% | -9.9% | +55.7% | -19.6% | -17.3% | +11.5% | -37.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +28.6% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | -100.0% | – | – | |
| – | -31.1% | -4.0% | -4.2% | -4.4% | -4.6% | -4.8% | -28.5% | -7.0% | -7.6% | +80.5% | -2.2% | |
| – | -0.2% | +17.6% | +6.9% | -24.5% | -16.2% | -2.0% | +19.9% | -1.8% | -3.6% | -5.3% | -22.0% | |
| – | +6.8% | +18.2% | -0.3% | -19.2% | -16.2% | -1.8% | +20.1% | -1.6% | -3.4% | -5.0% | -22.0% | |
| – | -5.3% | – | – | -4.6% | +1.8% | +1.6% | – | – | +1.7% | +1.6% | -16.0% | |
| – | -36.6% | +53.1% | -4.7% | -33.9% | -30.7% | -35.4% | +83.1% | -4.6% | +6.2% | +3.0% | -41.2% | |
| – | -15.2% | -0.3% | -3.3% | -3.3% | +3.1% | -0.3% | -46.4% | -16.5% | -23.9% | -11.7% | -20.6% | |
| – | -20.0% | -2.6% | -6.5% | +7.0% | +3.0% | -0.9% | -58.6% | -26.3% | -44.2% | -30.5% | -66.3% | |
| – | +0.2% | +3.8% | -3.4% | +2.4% | 0.0% | -1.5% | +1.0% | +0.3% | +0.6% | +0.1% | +3.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.